Collectively, these experiments suggest that HIF-2α-dependent vulnerability to combined inhibition of ATM and CK2 in VHL-deficient renal carcinoma cells may rely on a functional CK2–HIF-2α interaction. The gene discussed is EPAS1; the disease is renal carcinoma.